European Cystic Fibrosis Society (ECFS)
Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > ECFS Patient Registry Variables Conformity Survey

ECFS Patient Registry Variables Conformity Survey

ECFS Patient Registry Variables Conformity Survey

Thank you for sending your data to the ECFSPR.

To identify any differences in the variables definitions/coding between your national database and the ECFSPR we kindly ask you to fill in this questionnaire. The information will help us in the data analyses, and differences will be highlighted in the annual data report as appropriate. Your help and collaboration in this survey is greatly appreciated.

NB You do not need to login to submit this information.
 

Introductory Information
Please enter the email address where we can contact you.
1. DEMOGRAPHIC
1.1 Year of Birth
1.2. Month of birth
The ECFSPR requires this variable to be coded as follows: 2 digits (1 to 12) If unknown use 7
1.3. Day of birth
The ECFSPR requires this variable to be coded as follows: For data protection issues this field should be set to 15. We do not collect day of birth, only month and year.
1.4 Gender
The ECFSPR requires this variable to be coded as follows: 1 male 2 female
1.5 Status of patient on 31st December of the year of follow-up
The ECFSPR requires this variable to be coded as follows: -1 unknown or variable not collected 0 he/she died during the year of follow-up 1 he/she is alive on 31st December of the year of follow-up 2 not seen during the year of follow-up 3 lost to follow-up
1.6 Year of Death
The ECFSPR requires this variable to be coded as follows: 4 digits If patient is alive, leave blank If unknown use 9999
1.7 Month of Death
The ECFSPR requires this variable to be coded as follows: 2 digits (1 to 12) If unknown or patient is alive leave blank
1.8 Day of Death
The ECFSPR requires this variable to be coded as follows: 2 digits (1 to 31) If unknown or patient is alive leave blank
1.9 Cause of Death
The ECFSPR requires this variable to be coded as follows: -1 unknown -99 missing because the patient is alive or variable not collected 1 respiratory 2 liver GI 3 trauma 4 suicide 5 transplantation 6 non-CF related 7 cancer 8 other CF-related
2. DIAGNOSIS
2.1 Diagnosis confirmed according to the criteria for including patients in the ECFSPR
The ECFSPR requires this variable to be coded as follows: -1 unknown -99 missing (variable not collected) 0 no 1 yes 2 diagnosis to be confirmed
The ECFSPR definition for this variable is the following: 1. Two sweat tests value > 59 mmol/L chloride: CF diagnosis accepted. 2. One sweat test value > 59 mmol/L chloride + DNA Analysis/Genotyping – two identified disease-causing CF mutations: CF diagnosis accepted. 3. If the sweat value is less than or equal to 60 mmol/L chloride, or not reported, then at least 2 of the following must be fulfilled: a. DNA Analysis/Genotyping: two identified disease-causing CF mutations; b. NPD (Transepithelial (Nasal) Potential Difference) or ICM (Intestinal current measurement): result consistent with a diagnosis of CF; c. Clinical presentation: typical features of CF.
2.2 Age at diagnosis
The ECFSPR requires this variable to be coded as follows: Age of diagnosis in years (two decimals) If the age at diagnosis is unknown or the variable is not collected, use value -1
2.3 Neonatal screening
The ECFSPR requires this variable to be coded as follows: -1 unknown -99 missing (variable not collected) 0 not done 1 performed, result positive 2 performed, result negative 3 performed, result unknown
2.4 Meconium Ileus
The ECFSPR requires this variable to be coded as follows: -1 unknown -99 missing (variable not collected) 0 no 1 yes, operated 2 yes, not operated 3 yes, don't know if operated
2.5 First mutation
The ECFSPR requires this variable to be coded as follows: If genotyping was not performed, then use "not done" for both mutations. If genotyping was performed, but none of the two mutations were identified, please use "unknown" for both mutations. If genotyping was performed, but one of the two mutations was not identified, please use "unknown" for that mutation, do not leave it blank. If the spelling of the mutation name is not in the list at the end of this document, please use "Other" and write the mutation name in the variable "Other first mutation".
2.6 Second mutation
The ECFSPR requires this variable to be coded as follows: If genotyping was not performed, then use "not done" for both mutations. If genotyping was performed, but none of the two mutations were identified, please use "unknown" for both mutations. If genotyping was performed, but one of the two mutations was not identified, please use "unknown" for that mutation, do not leave it blank. If the spelling of the mutation name is not in the list at the end of this document, please use "Other" and write the mutation name in the variable "Other second mutation".
2.7 Type of sweat test
The ECFSPR requires this variable to be coded as follows: -1 unknown -99 missing (variable not collected) 0 not done 1 titration 2 conductivity
The ECFSPR definition for this variable is the following: If patient has not undergone sweat testing, record as “not done”. If a sweat test is “not done” then two known genotype mutations must be reported. i. Sweat Test: record the patient's sweat test; ii. Electrolytes: Chloride concentration measurement is the preferred analysis; iii. Chloride value: report the Chloride value in millimols per litre (mmol/L). If duplicate tests were carried out on the same day, report the highest positive value. NOTE: The acceptable range for Chloride values is 1-160 mmol/L. Anyone who has a Chloride value above 160 mmol/L must be re-tested.
2.8 Electrolytes
The ECFSPR requires this variable to be coded as follows: -1 unknown -99 missing (variable not collected) 0 not done 1 chloride 4 other
The ECFSPR definition for this variable is the following: If patient has not undergone sweat testing, record as “not done”. If a sweat test is “not done” then two known genotype mutations must be reported. i. Sweat Test: record the patient's sweat test; ii. Electrolytes: Chloride concentration measurement is the preferred analysis; iii. Chloride value: report the Chloride value in millimols per litre (mmol/L). If duplicate tests were carried out on the same day, report the highest positive value. NOTE: The acceptable range for Chloride values is 1-160 mmol/L. Anyone who has a Chloride value above 160 mmol/L must be re-tested.
2.9 Sweat test value
The ECFSPR requires this variable to be coded as follows: If the value is unknown or if the variable is not collected, use value -1
The ECFSPR definition for this variable is the following: If patient has not undergone sweat testing, record as “not done”. If a sweat test is “not done” then two known genotype mutations must be reported. i. Sweat Test: record the patient's sweat test; ii. Electrolytes: Chloride concentration measurement is the preferred analysis; iii. Chloride value: report the Chloride value in millimols per litre (mmol/L). If duplicate tests were carried out on the same day, report the highest positive value. NOTE: The acceptable range for Chloride values is 1-170 mmol/L. Anyone who has a Chloride value above 170 mmol/L must be re-tested.
2.10 Nasal Potential Difference - NPD
The ECFSPR requires this variable to be coded as follows: -1 unknown -99 missing (variable not collected) 0 not done 1 test done
2.11 CF-typical NPD
The ECFSPR requires this variable to be coded as follows: -1 unknown -99 missing (variable not collected. Use if NPD= -1, -99 or 0) 0 no, not CF-typical NPD measurement 1 yes, CF-typical NPD measurement 2 indeterminate measurement
2.12 Date of NPD Year
Enter year of NPD measurement (4 digits); if year is unknown, use 9999. If NPD = -1/-99/0, leave blank
2.13 Date of NPD Month
Enter number of month of NPD measurement, max 2 digits; If month unknown, use 7. If patient born after 1/07, use date of diagnosis or 31/12; If NPD = -1/-99/0, leave blank.
2.14 Date of NPD Day
Enter day of the month of NPD measurement, max 2 digits. If day is unknown but month is known, use 15 for the day; if both month & day unknown, use 01 (01/07) or date of diagnosis or 31 (31/12); If NPD = - 1/-99/0, leave blank.
2.15 Intestinal Current Measurement
The ECFSPR requires this variable to be coded as follows: -1 unknown -99 missing (variable not collected) 0 test not done 1 test done
2.16 CF-typical ICM
The ECFSPR requires this variable to be coded as follows: -1 unknown -99 missing (variable not collected. Use if ICM = -1, -99 or 0) 0 no, not CF-typical ICM measurement 1 yes, CF-typical ICM measurement 2 indeterminate measurement
2.17 Date of ICM Year
Enter year of ICM measurement; if year is unknown, use 9999 . If ICM = -1/-99/0, leave blank
2.18 Date of ICM Month
Enter number of month of ICM measurement, max 2 digits. If month unknown, use 7. If patient born after 1/07, use date of diagnosis or 31/12. If ICM = -1/-99/0, leave blank.
2.19 Date of ICM Day
Enter day of the month of ICM measurement, max 2 digits; If day is unknown but month is known, use 15 for the day; if both month & day unknown, use 01 (01/07) or date of diagnosis or 31 (31/12); If ICM = - 1/-99/0, leave blank.
3. THERAPY
3.1 Inhaled continuous (>3 months) hypertonic NaCl during the year of follow-up
The ECFSPR requires this variable to be coded as follows: -1 unknown -99 missing (variable not collected) 0 no 1 yes
3.2 Inhaled continuous (>3 months) Mannitol during the year of follow-up
The ECFSPR requires this variable to be coded as follows: -1 unknown -99 missing (variable not collected) 0 no 1 yes
3.3 Inhaled continuous (>3 months) antibiotic during the year of follow-up
The ECFSPR requires this variable to be coded as follows: -1 unknown -99 missing (variable not collected) 0 no 1 yes
3.4 Inhaled continuous (>3 months) bronchodilators during the year of follow-up
The ECFSPR requires this variable to be coded as follows: -1 unknown -99 missing (variable not collected) 0 no 1 yes
3.5 In oxygen therapy the year of follow-up
The ECFSPR requires this variable to be coded as follows: -1 unknown -99 missing (variable not collected) 0 no 1 yes
3.6 Continuous (>3 months) NIPPV during the year of follow-up
The ECFSPR requires this variable to be coded as follows: -1 unknown -99 missing (variable not collected) 0 no 1 yes – CPAP 2 yes - BiPAP
3.7 Use of rhDNase during the year of follow-up
The ECFSPR requires this variable to be coded as follows: -1 unknown -99 missing (variable not collected) 0 no 1 yes
3.8 Continuous (>3 months) inhaled steroids during the year of follow-up
The ECFSPR requires this variable to be coded as follows: -1 unknown -99 missing (variable not collected) 0 no 1 yes
3.9 Continuous (>3 months) oral steroids during the year of follow-up
The ECFSPR requires this variable to be coded as follows: -1 unknown -99 missing (variable not collected) 0 no 1 yes
3.10 Use of continuous (>3 months) Azithromicin (or other macrolide) during the year of follow-up
The ECFSPR requires this variable to be coded as follows: -1 unknown -99 missing (variable not collected) 0 no 1 yes
3.11 Use of ursodeoxycholic acid during the year of follow-up
The ECFSPR requires this variable to be coded as follows: -1 unknown -99 missing (variable not collected) 0 no 1 yes
3.12 Use of pancreatic enzymes during the year of follow-up
The ECFSPR requires this variable to be coded as follows: -1 unknown -99 missing (variable not collected) 0 no 1 yes
3.13 Continuous (>3 months) Proton Pump Inhibitors during the year of follow-up
The ECFSPR requires this variable to be coded as follows: -1 unknown -99 missing (variable not collected) 0 no 1 yes
3.14 Ivacaftor during the year of follow-up
The ECFSPR requires this variable to be coded as follows: -1 unknown -99 missing (variable not collected) 0 no 1 yes
3.15 Start Year of Ivacaftor Treatment
The ECFSPR requires this variable to be coded as follows: If no Ivacaftor, leave blank; If “yes” to Ivacaftor, start year is required and must be equal to or before the year of follow-up; Use start year - max 4 digits; If you do not know the year therapy started but you know that it is before the current year of follow-up (CYFU) and therapy has continued to the CFYU, 01/01/XXXX (where XXXX = CYFU) should be used for the date of start of Ivacaftor. If no is selected at 3.15.1, box to open with this text:
The ECFSPR requires this variable to be coded as follows: If no Ivacaftor, leave blank; If “yes” for Ivacaftor, start year is required. See above, including defaults for unknown dates.
3.16 Start Month of Ivacaftor Treatment
The ECFSPR requires this variable to be coded as follows: If no Ivacaftor, leave blank; If “yes” for Ivacaftor, start month is required; Use start month - max 2 digits (1-12); Month unknown: if the start year is before the current year of follow up and only the month is unknown, 7 should be used for the month (see previous, if both start year and month are unknown); If the start year is the same as the year of follow-up, 7 should be used for the month;
The ECFSPR requires this variable to be coded as follows: If no Ivacaftor, leave blank; If “yes” for Ivacaftor, start month is required. See above, including defaults for unknown dates.
3.17 Start Day of Ivacaftor Treatment
The ECFSPR requires this variable to be coded as follows: If no Ivacaftor, leave blank; If “yes” for Ivacaftor, start day is required; Use start day - max 2 digits; Use day of the month Ivacaftor therapy started (max 2 digits); Day unknown: if only the day is unknown, 15 should be used for the day; If both day and month are unknown, 1 should be used for the day and 7 for the month (01/07); If day, month and year are unknown, 01/01/XXXX should be used (where XXXX = current year of follow up).
The ECFSPR requires this variable to be coded as follows: If no Ivacaftor, leave blank; If “yes” for Ivacaftor, start day is required. See above, including defaults for unknown dates.
3.18 Stop Year of Ivacaftor Treatment
The ECFSPR requires this variable to be coded as follows: If no Ivacaftor, leave blank; If treatment stopped in current year of follow-up (CYFU), current year should be used; 4 digits; If the treatment stopped before CYFU, "no" for Ivacaftor should be used and no dates should be provided; If the therapy started during or before CYFU and continued to the next year, no year should be entered (you are asked to confirm in ECFSTracker that no stop date = continuing to the next year); If you know patient was taking therapy in CYFU but you don’t know if the therapy continued to the next year you should really try to recover this information. If you really cannot recover this information use CYFU (full unknown stop date 31/12/2019);
The ECFSPR requires this variable to be coded as follows: If no Ivacaftor, leave blank; If “yes” for Ivacaftor, stop year is required. See above, including defaults for unknown dates.
3.19 Stop Month of Ivacaftor Treatment
The ECFSPR requires this variable to be coded as follows: If no Ivacaftor in current year of follow-up (CYFU), leave blank; If stopped in current year of follow up (CYFU), use the number of the month (max 2 digits); If stopped in CYFU and the month is unknown please recover this information. If you really cannot recover this information 12 should be used (31/12 is unknown stop date);
The ECFSPR requires this variable to be coded as follows: If no Ivacaftor, leave blank; If “yes” for Ivacaftor, stop month is required. See above, including defaults for unknown dates.
3.20 Stop Day of Ivacaftor Treatment
The ECFSPR requires this variable to be coded as follows: If no Ivacaftor in current year of follow-up (CYFU), leave blank; If stopped in current year of follow up (CYFU), use the number of the day (max 2 digits); If stopped in CYFU and only the day is unknown please recover this information. If you really cannot recover this information 15 should be used; If stopped in CYFU and both month & day are unknown, but year is known, use 31/12.
The ECFSPR requires this variable to be coded as follows: If no Ivacaftor, leave blank; If “yes” for Ivacaftor, stop day is required. See above, including defaults for unknown dates.
3.21 Lumacaftor / Ivacaftor during the year of follow-up
The ECFSPR requires this variable to be coded as follows: -1 unknown -99 missing (variable not collected) 0 no 1 yes
3.22 Start Year of Lumacaftor / Ivacaftor Treatment
The ECFSPR requires this variable to be coded as follows: If no Lumacaftor / Ivacaftor, leave blank; If “yes” to Lumacaftor / Ivacaftor, start year is required and must be equal to or before the year of follow-up; Use start year - max 4 digits; If you do not know the year therapy started but you know that it is before the current year of follow-up (CYFU) and therapy has continued to the CFYU, 01/01/XXXX (where XXXX = CYFU) should be used for the date of start of Lumacaftor / Ivacaftor.
The ECFSPR requires this variable to be coded as follows: If no Lumacaftor / Ivacaftor, leave blank; If “yes” for Lumacaftor / Ivacaftor, start year is required. See above, including defaults for unknown dates.
3.23 Start Month of Lumacaftor / Ivacaftor Treatment
The ECFSPR requires this variable to be coded as follows: If no Lumacaftor / Ivacaftor, leave blank; If “yes” for Lumacaftor / Ivacaftor, start month is required; Use start month - max 2 digits (1-12); Month unknown: if the start year is before the current year of follow up and only the month is unknown, 7 should be used for the month (see previous, if both start year and month are unknown); If the start year is the same as the year of follow-up, 7 should be used for the month;
The ECFSPR requires this variable to be coded as follows: If no Lumacaftor / Ivacaftor, leave blank; If “yes” for Lumacaftor / Ivacaftor, start month is required. See above, including defaults for unknown dates.
3.24 Start Day of Lumacaftor / Ivacaftor Treatment
The ECFSPR requires this variable to be coded as follows: If no Lumacaftor / Ivacaftor, leave blank; If “yes” for Lumacaftor / Ivacaftor, start day is required; Use start day - max 2 digits; Use day of the month Lumacaftor / Ivacaftor therapy started (max 2 digits); Day unknown: if only the day is unknown, 15 should be used for the day; If both day and month are unknown, 1 should be used for the day and 7 for the month (01/07); If day, month and year are unknown, 01/01/XXXX should be used (where XXXX = current year of follow up).
The ECFSPR requires this variable to be coded as follows: If no Lumacaftor / Ivacaftor, leave blank; If “yes” for Lumacaftor / Ivacaftor, start day is required. See above, including defaults for unknown dates.
3.25 Stop Year of Lumacaftor / Ivacaftor Treatment
The ECFSPR requires this variable to be coded as follows: If no Lumacaftor / Ivacaftor, leave blank; If treatment stopped in current year of follow-up (CYFU), current year should be used; 4 digits If the treatment stopped before CYFU, "no" for Lumacaftor / Ivacaftor should be used and no dates should be provided; If the therapy started during or before CYFU and continued to the next year, no year should be entered (you are asked to confirm in ECFSTracker that no stop date = continuing to the next year); If you know patient was taking therapy in CYFU but you don’t know if the therapy continued to the next year you should really try to recover this information. If you really cannot recover this information use CYFU (full unknown stop date 31/12/2019);
The ECFSPR requires this variable to be coded as follows: If no Lumacaftor / Ivacaftor, leave blank; If “yes” for Lumacaftor / Ivacaftor, stop year is required. See above, including defaults for unknown dates.
3.26 Stop Month of Lumacaftor / Ivacaftor Treatment
The ECFSPR requires this variable to be coded as follows: If no Lumacaftor / Ivacaftor in current year of follow-up (CYFU), leave blank; If stopped in current year of follow up (CYFU), use the number of the month (max 2 digits); If stopped in CYFU and the month is unknown please recover this information. If you really cannot recover this information 12 should be used (31/12 is unknown stop date;
The ECFSPR requires this variable to be coded as follows: If no Lumacaftor / Ivacaftor, leave blank; If “yes” for Lumacaftor / Ivacaftor, stop month is required. See above, including defaults for unknown dates.
3.27 Stop Day of Lumacaftor / Ivacaftor Treatment
The ECFSPR requires this variable to be coded as follows: If no Lumacaftor / Ivacaftor in current year of follow-up (CYFU), leave blank; If stopped in current year of follow up (CYFU), use the number of the day (max 2 digits); If stopped in CYFU and only the day is unknown please recover this information. If you really cannot recover this information 15 should be used; If stopped in CYFU and both month & day are unknown, but year is known, use 31/12.
The ECFSPR requires this variable to be coded as follows: If no Lumacaftor / Ivacaftor, leave blank; If “yes” for Lumacaftor / Ivacaftor, stop day is required. See above, including defaults for unknown dates.
3.28 Tezacaftor / Ivacaftor during the year of follow-up
The ECFSPR requires this variable to be coded as follows: -1 unknown -99 missing (variable not collected) 0 no 1 yes
3.29 Start Year of Tezacaftor / Ivacaftor Treatment
The ECFSPR requires this variable to be coded as follows: If no Tezacaftor / Ivacaftor, leave blank; If “yes” to Tezacaftor / Ivacaftor, start year is required and must be equal to or before the year of follow-up; Use start year - max 4 digits; If you do not know the year therapy started but you know that it is before the current year of follow-up (CYFU) and therapy has continued to the CFYU, 01/01/XXXX (where XXXX = CYFU) should be used for the date of start of Tezacaftor / Ivacaftor.
The ECFSPR requires this variable to be coded as follows: If no Tezacaftor / Ivacaftor, leave blank; If “yes” for Tezacaftor / Ivacaftor, start year is required. See above, including defaults for unknown dates.
3.30 Start Month of Tezacaftor / Ivacaftor Treatment
The ECFSPR requires this variable to be coded as follows: If no Tezacaftor / Ivacaftor, leave blank; If “yes” for Tezacaftor / Ivacaftor, start month is required; Use start month - max 2 digits (1-12); Month unknown: if the start year is before the current year of follow up and only the month is unknown, 7 should be used for the month (see previous, if both start year and month are unknown); If the start year is the same as the year of follow-up, 7 should be used for the month;
The ECFSPR requires this variable to be coded as follows: If no Tezacaftor / Ivacaftor, leave blank; If “yes” for Tezacaftor / Ivacaftor, start month is required. See above, including defaults for unknown dates.
3.31 Start Day of Tezacaftor / Ivacaftor Treatment
The ECFSPR requires this variable to be coded as follows: If no Tezacaftor / Ivacaftor, leave blank; If “yes” for Tezacaftor / Ivacaftor, start day is required; Use start day - max 2 digits; Use day of the month Tezacaftor / Ivacaftor therapy started (max 2 digits); Day unknown: if only the day is unknown, 15 should be used for the day; If both day and month are unknown, 1 should be used for the day and 7 for the month (01/07); If day, month and year are unknown, 01/01/XXXX should be used (where XXXX = current year of follow up).
The ECFSPR requires this variable to be coded as follows: If no Tezacaftor / Ivacaftor, leave blank; If “yes” for Tezacaftor / Ivacaftor, start day is required. See above, including defaults for unknown dates.
3.32 Stop Year of Tezacaftor / Ivacaftor Treatment
The ECFSPR requires this variable to be coded as follows: If no Tezacaftor / Ivacaftor, leave blank; If treatment stopped in current year of follow-up (CYFU), current year should be used; 4 digits If the treatment stopped before CYFU, "no" for Tezacaftor / Ivacaftor should be used and no dates should be provided; If the therapy started during or before CYFU and continued to the next year, no year should be entered (you are asked to confirm in ECFSTracker that no stop date = continuing to the next year); If you know patient was taking therapy in CYFU but you don’t know if the therapy continued to the next year you should really try to recover this information. If you really cannot recover this information use CYFU (full unknown stop date 31/12/2019);
The ECFSPR requires this variable to be coded as follows: If no Tezacaftor / Ivacaftor, leave blank; If “yes” for Tezacaftor / Ivacaftor, stop year is required. See above, including defaults for unknown dates.
3.33 Stop Month of Tezacaftor / Ivacaftor Treatment
The ECFSPR requires this variable to be coded as follows: If no Tezacaftor / Ivacaftor in current year of follow-up (CYFU), leave blank; If stopped in current year of follow up (CYFU), use the number of the month (max 2 digits); If stopped in CYFU and the month is unknown please recover this information. If you really cannot recover this information 12 should be used (31/12 is unknown stop date;
The ECFSPR requires this variable to be coded as follows: If no Tezacaftor / Ivacaftor, leave blank; If “yes” for Tezacaftor / Ivacaftor, stop month is required. See above, including defaults for unknown dates.
3.34 Stop Day of Tezacaftor / Ivacaftor Treatment
The ECFSPR requires this variable to be coded as follows: If no Tezacaftor / Ivacaftor in current year of follow-up (CYFU), leave blank; If stopped in current year of follow up (CYFU), use the number of the day (max 2 digits); If stopped in CYFU and only the day is unknown please recover this information. If you really cannot recover this information 15 should be used; If stopped in CYFU and both month & day are unknown, but year is known, use 31/12.
The ECFSPR requires this variable to be coded as follows: If no Tezacaftor / Ivacaftor, leave blank; If “yes” for Tezacaftor / Ivacaftor, stop day is required. See above, including defaults for unknown dates.
3.35 Elexacaftor / Tezacaftor / Ivacaftor during the year of follow-up
The ECFSPR requires this variable to be coded as follows: -1 unknown -99 missing (variable not collected) 0 no 1 yes
3.36 Start Year of Elexacaftor / Tezacaftor / Ivacaftor Treatment
The ECFSPR requires this variable to be coded as follows: If no Elexacaftor / Tezacaftor / Ivacaftor, leave blank; If “yes” to Elexacaftor / Tezacaftor / Ivacaftor, start year is required and must be equal to or before the year of follow-up; Use start year - max 4 digits; If you do not know the year therapy started but you know that it is before the current year of follow-up (CYFU) and therapy has continued to the CFYU, 01/01/XXXX (where XXXX = CYFU) should be used for the date of start of Elexacaftor / Tezacaftor / Ivacaftor.
The ECFSPR requires this variable to be coded as follows: If no Elexacaftor / Tezacaftor / Ivacaftor, leave blank; If “yes” for Elexacaftor / Tezacaftor / Ivacaftor, start year is required. See above, including defaults for unknown dates.
3.37 Start Month of Elexacaftor / Tezacaftor / Ivacaftor Treatment
The ECFSPR requires this variable to be coded as follows: If no Elexacaftor / Tezacaftor / Ivacaftor, leave blank; If “yes” for Elexacaftor / Tezacaftor / Ivacaftor, start month is required; Use start month - max 2 digits (1-12); Month unknown: if the start year is before the current year of follow up and only the month is unknown, 7 should be used for the month (see previous, if both start year and month are unknown); If the start year is the same as the year of follow-up, 7 should be used for the month;
The ECFSPR requires this variable to be coded as follows: If no Elexacaftor / Tezacaftor / Ivacaftor, leave blank; If “yes” for Elexacaftor / Tezacaftor / Ivacaftor, start month is required. See above, including defaults for unknown dates.
3.38 Start Day of Elexacaftor / Tezacaftor / Ivacaftor Treatment
The ECFSPR requires this variable to be coded as follows: If no Elexacaftor / Tezacaftor / Ivacaftor, leave blank; If “yes” for Elexacaftor / Tezacaftor / Ivacaftor, start day is required; Use start day - max 2 digits; Use day of the month Elexacaftor / Tezacaftor / Ivacaftor therapy started (max 2 digits); Day unknown: if only the day is unknown, 15 should be used for the day; If both day and month are unknown, 1 should be used for the day and 7 for the month (01/07); If day, month and year are unknown, 01/01/XXXX should be used (where XXXX = current year of follow up).
The ECFSPR requires this variable to be coded as follows: If no Elexacaftor / Tezacaftor / Ivacaftor, leave blank; If “yes” for Elexacaftor / Tezacaftor / Ivacaftor, start day is required. See above, including defaults for unknown dates.
3.39 Stop Year of Elexacaftor / Tezacaftor / Ivacaftor Treatment
The ECFSPR requires this variable to be coded as follows: If no Elexacaftor / Tezacaftor / Ivacaftor, leave blank; If treatment stopped in current year of follow-up (CYFU), current year should be used; 4 digits If the treatment stopped before CYFU, "no" for Elexacaftor / Tezacaftor / Ivacaftor should be used and no dates should be provided; If the therapy started during or before CYFU and continued to the next year, no year should be entered (you are asked to confirm in ECFSTracker that no stop date = continuing to the next year); If you know patient was taking therapy in CYFU but you don’t know if the therapy continued to the next year you should really try to recover this information. If you really cannot recover this information use CYFU (full unknown stop date 31/12/2019);
The ECFSPR requires this variable to be coded as follows: If no Elexacaftor / Tezacaftor / Ivacaftor, leave blank; If “yes” for Elexacaftor / Tezacaftor / Ivacaftor, stop year is required. See above, including defaults for unknown dates.
3.40 Stop Month of Elexacaftor / Tezacaftor / Ivacaftor Treatment
The ECFSPR requires this variable to be coded as follows: If no Elexacaftor / Tezacaftor / Ivacaftor in current year of follow-up (CYFU), leave blank; If stopped in current year of follow up (CYFU), use the number of the month (max 2 digits); If stopped in CYFU and the month is unknown please recover this information. If you really cannot recover this information 12 should be used (31/12 is unknown stop date;
The ECFSPR requires this variable to be coded as follows: If no Elexacaftor / Tezacaftor / Ivacaftor, leave blank; If “yes” for Elexacaftor / Tezacaftor / Ivacaftor, stop month is required. See above, including defaults for unknown dates.
3.41 Stop Day of Elexacaftor / Tezacaftor / Ivacaftor Treatment
The ECFSPR requires this variable to be coded as follows: If no Elexacaftor / Tezacaftor / Ivacaftor in current year of follow-up (CYFU), leave blank; If stopped in current year of follow up (CYFU), use the number of the day (max 2 digits); If stopped in CYFU and only the day is unknown please recover this information. If you really cannot recover this information 15 should be used; If stopped in CYFU and both month & day are unknown, but year is known, use 31/12.
The ECFSPR requires this variable to be coded as follows: If no Elexacaftor / Tezacaftor / Ivacaftor, leave blank; If “yes” for Elexacaftor / Tezacaftor / Ivacaftor, stop day is required. See above, including defaults for unknown dates.
3.42 Other CFTR Modulator during the year of follow-up
The ECFSPR requires this variable to be coded as follows: -1 unknown -99 missing (variable not collected) 0 no 1 yes
3.43 Start Year of Other CFTR Modulator Treatment
The ECFSPR requires this variable to be coded as follows: If no Other CFTR Modulator, leave blank; If “yes” to Other CFTR Modulator, start year is required and must be equal to or before the year of follow-up; Use start year - max 4 digits; If you do not know the year therapy started but you know that it is before the current year of follow-up (CYFU) and therapy has continued to the CFYU, 01/01/XXXX (where XXXX = CYFU) should be used for the date of start of Other CFTR Modulator.
The ECFSPR requires this variable to be coded as follows: If no Other CFTR Modulator, leave blank; If “yes” for Other CFTR Modulator, start year is required. See above, including defaults for unknown dates.
3.44 Start Month of Other CFTR Modulator Treatment
The ECFSPR requires this variable to be coded as follows: If no Other CFTR Modulator, leave blank; If “yes” for Other CFTR Modulator, start month is required; Use start month - max 2 digits (1-12); Month unknown: if the start year is before the current year of follow up and only the month is unknown, 7 should be used for the month (see previous, if both start year and month are unknown); If the start year is the same as the year of follow-up, 7 should be used for the month;
The ECFSPR requires this variable to be coded as follows: If no Other CFTR Modulator, leave blank; If “yes” for Other CFTR Modulator, start month is required. See above, including defaults for unknown dates.
3.45 Start Day of Other CFTR Modulator Treatment
The ECFSPR requires this variable to be coded as follows: If no Other CFTR Modulator, leave blank; If “yes” for Other CFTR Modulator, start day is required; Use start day - max 2 digits; Use day of the month Other CFTR Modulator therapy started (max 2 digits); Day unknown: if only the day is unknown, 15 should be used for the day; If both day and month are unknown, 1 should be used for the day and 7 for the month (01/07); If day, month and year are unknown, 01/01/XXXX should be used (where XXXX = current year of follow up).
The ECFSPR requires this variable to be coded as follows: If no Other CFTR Modulator, leave blank; If “yes” for Other CFTR Modulator, start day is required. See above, including defaults for unknown dates.
3.46 Stop Year of Other CFTR Modulator Treatment
The ECFSPR requires this variable to be coded as follows: If no Other CFTR Modulator, leave blank; If treatment stopped in current year of follow-up (CYFU), current year should be used; 4 digits If the treatment stopped before CYFU, "no" for Other CFTR Modulator should be used and no dates should be provided; If the therapy started during or before CYFU and continued to the next year, no year should be entered (you are asked to confirm in ECFSTracker that no stop date = continuing to the next year); If you know patient was taking therapy in CYFU but you don’t know if the therapy continued to the next year you should really try to recover this information. If you really cannot recover this information use CYFU (full unknown stop date 31/12/2019);
The ECFSPR requires this variable to be coded as follows: If no Other CFTR Modulator, leave blank; If “yes” for Other CFTR Modulator, stop year is required. See above, including defaults for unknown dates.
3.47 Stop Month of Other CFTR Modulator Treatment
The ECFSPR requires this variable to be coded as follows: If no Other CFTR Modulator in current year of follow-up (CYFU), leave blank; If stopped in current year of follow up (CYFU), use the number of the month (max 2 digits); If stopped in CYFU and the month is unknown please recover this information. If you really cannot recover this information 12 should be used (31/12 is unknown stop date;
The ECFSPR requires this variable to be coded as follows: If no Other CFTR Modulator, leave blank; If “yes” for Other CFTR Modulator, stop month is required. See above, including defaults for unknown dates.
3.48 Stop Day of Other CFTR Modulator Treatment
The ECFSPR requires this variable to be coded as follows: If no Other CFTR Modulator in current year of follow-up (CYFU), leave blank; If stopped in current year of follow up (CYFU), use the number of the day (max 2 digits); If stopped in CYFU and only the day is unknown please recover this information. If you really cannot recover this information 15 should be used; If stopped in CYFU and both month & day are unknown, but year is known, use 31/12.
The ECFSPR requires this variable to be coded as follows: If no Other CFTR Modulator, leave blank; If “yes” for Other CFTR Modulator, stop day is required. See above, including defaults for unknown dates.
4. LUNG FUNCTION AND NUTRITION
4.1 Weight measured at date of FEV1 (of best FEV1% of predicted) or, if no lung function test, last weight of the year of follow-up
The ECFSPR requires this variable to be coded as follows: Weight in kg (one decimal) If the value is unknown or if the variable is not collected, use value -1
The ECFSPR definition for this variable is the following: Measurements: weight and height are measured according to EuroCareCF guidelines: a. weight: removal of outer clothing, shoes and socks; b. height: without shoes and socks - stadiometer - top of head in contact with head board, slight pressure; c. it should be the value at the day of the recorded FEV1; or if no lung function test, last weight of the year of follow-up Z-scores for height, weight and BMI will be calculated using the CDC reference values [Kuczmarski et al (2002)].
4.2 Height measured at date of FEV1 (of best FEV1% of predicted) or, if no lung function test, last height of the year of follow-up
The ECFSPR requires this variable to be coded as follows: Height in cm (no decimals) If the value is unknown or if the variable is not collected, use value -1
The ECFSPR definition for this variable is the following: Measurements: weight and height are measured according to EuroCareCF guidelines: a. weight: removal of outer clothing, shoes and socks; b. height: without shoes and socks - stadiometer - top of head in contact with head board, slight pressure; c. it should be the value at the day of the recorded FEV1; or if no lung function test, last height of the year of follow-up. Z-scores for height, weight and BMI will be calculated using the CDC reference values [Kuczmarski et al (2002)].
4.3 Month of FEV1 measurement
The ECFSPR requires this variable to be coded as follows: 2 digits (1 to 12) If unknown use 7 (unknown date of FEV1 measurement is 01-07) If no lung function nor growth data is present, leave blank
4.4 Day of FEV1 measurement
The ECFSPR requires this variable to be coded as follows: 2 digits (1 to 31) If the day is unknown, bu the month is known, use 15. If the day and the month are unknown, use 1 (unknown date of FEV1 measurement is 01-07) If no lung function nor growth data is present, leave blank
4.5 Value of FEV1 of best FEV1% of predicted during the year of follow-up
The ECFSPR requires this variable to be coded as follows: Value in litres (2 decimals) of the FEV1 of the highest FEV1% of predicted of the year according to local reference values. If the value is unknown or if the variable is not collected, use value -1
The ECFSPR definition for this variable is the following: a. for values reported to national registries or to centres and sent to the ECFSPR, it is the value in litres of the FEV1 of the highest FEV1% predicted (according to local references) of the year which should be extracted; b. each patient's FVC and FEV1 measurements must be reported in litres (L), with up to two places to the right of the decimal; c. the FVC measurement must be greater than or equal to the FEV1 measurement; d. for the reported spirometry value, the date of the test and the patient’s height at that date should be reported in order to perform the calculation of the percent of predicted values; e. only tests deemed valid according to ATC/ERS guidelines should be reported.
4.6 Value of FVC of the reported FEV1 of highest FEV1% of predicted during the year of follow-up
The ECFSPR requires this variable to be coded as follows: Value in litres (2 decimals) of the FVC of the reported FEV1 of the highest FEV1% of predicted of the year according to local reference values. If the value is unknown or if the variable is not collected, use value -1
The ECFSPR definition for this variable is the following: a. for values reported to national registries or to centres and sent to the ECFSPR, litres of the FVC (according to local references) of the recorded FEV1 of the highest FEV1% of predicted of the year which should be extracted; b. each patient's FVC and FEV1 measurements must be reported in litres (L), with up to two places to the right of the decimal; c. the FVC measurement must be greater than or equal to the FEV1 measurement; d. for each reported spirometry value, the date of the test and the patient’s height at that date should be reported in order to perform the calculation of the percent of predicted values; e. only tests deemed valid according to ATC/ERS guidelines should be reported.
4.7 Lowest Lung Clearance Index 2,5% during the year of follow-up
The ECFSPR requires this variable to be coded as follows: Record value of lowest LCI 2.5% during the year of follow-up; if unknown or not collected use -1. The value should be between 2 and 25.
4.8 Date of lowest LCI 2,5% this year - month
The ECFSPR requires this variable to be coded as follows: Enter number corresponding to month of lowest LCI2.5%; If month is unknown, use '7'. If the patient was born after 1/7 of the year of follow-up use 12 (for 31/12); If no LCI 2.5% (LCI2.5% = -1) do not enter a date; leave blank.
4.9 Date of lowest LCI 2,5% this year - day
The ECFSPR requires this variable to be coded as follows: Enter day of the month of lowest LCI2.5%; If only the day is unknown but the month is known, use 15 for the day; If both day & month are unknown, use 1 (for 1/7); If the patient was born after 1/7 of the year of follow-up use 31 (for 31/12); If no LCI 2.5% do not enter a date - leave blank.
4.10 Device used for lowest LCI 2.5%
The ECFSPR requires this variable to be coded as follows: -1 device unknown -99 missing (variable not collected/LCI = -1) 1 Ecomedics Exhalyzer D N2-Washout 2 Ecomedics Exhalyzer SF6 (Tracergas 4%). 3 Innovision Innocor 4 NDD Easyone Pro 5 Other, not listed
5. MICROBIOLOGY
5.1 Chronic Pseudomonas aeruginosa
The ECFSPR requires this variable to be coded as follows: -1 unknown -99 missing (variable not collected) 0 no 1 yes
The ECFSPR definition for this variable is the following: 1. Chronic Pseudomonas aeruginosa infection: A patient should be considered chronically infected if the modified Leeds criteria are met (a) below, and/or anti-pseudomonas antibodies are detected (b) below. A patient should be defined as chronically infected if he/she fulfils the criteria now, or has done so in recent years, and the physician has no reason to think that the status has changed: a) Modified Leeds criteria - chronic infection: >50% of the samples (sputum/other) collected during the last 12 months should be positive; at least 4 samples collected. b) Significantly raised levels of anti-pseudomonas antibodies according to local laboratories. 2. Chronic infection with other gram-negative or gram-positive bacteria should meet the same criteria as described above.
5.2 Chronic Staphylococcus aureus
The ECFSPR requires this variable to be coded as follows: -1 unknown -99 missing (variable not collected) 0 no 1 yes
The ECFSPR definition for this variable is the following: 1. Chronic Staphylococcus aureus infection should be defined by the local physician in accordance with the modified Leeds criteria and/or the presence of anti-Staphylococcus aureus antibodies. Patient should be defined as chronically infected if he/she fulfils the criteria now or has done so in recent years and the physician has no reason to think the status has changed- a. modified Leeds criteria, chronic infection: >50% of the sputum samples positive, collected during the last 12 months. At least 4 sputum samples during that period; b. and/or significantly raised anti-Staphylococcus aureus antibodies according to local laboratories; 2. Chronic infection with other gram-negative bacteria should be recorded using the same criteria as above.
5.3 Chronic Burkholderia cepacia
The ECFSPR requires this variable to be coded as follows: -1 unknown -99 missing (variable not collected) 0 no 1 yes
The ECFSPR definition for this variable is the following: 1. Chronic Burkholderia cepacia infection should be defined by the local physician in accordance with the modified Leeds criteria and/or the presence of anti- Burkholderia cepacia antibodies. Patient should be defined as chronically infected if he/she fulfils the criteria now or has done so in recent years and the physician has no reason to think the status has changed- a. modified Leeds criteria, chronic infection: >50% of the sputum samples positive, collected during the last 12 months. At least 4 sputum samples during that period; b. and/or significantly raised anti- Burkholderia cepacia antibodies according to local laboratories; 2. Chronic infection with other gram-negative bacteria should be recorded using the same criteria as above.
5.4 Haemophilus influenzae this year
The ECFSPR requires this variable to be coded as follows: -1 unknown -99 missing (variable not collected) 0 no 1 yes, at least once during the year of follow-up
5.5 Nontuberculous mycobacteria during the year of follow-up
The ECFSPR requires this variable to be coded as follows: -1 unknown -99 missing (variable not collected) 0 never during the year of follow-up 1 yes, at least once during the year of follow-up
5.6 Stenotrophomonas maltophilia during the year of follow-up
The ECFSPR requires this variable to be coded as follows: -1 unknown -99 missing (variable not collected) 0 never during the year of follow-up 1 yes, at least once during the year of follow-up
5.7 Achromobacter spp (species) this year
The ECFSPR requires this variable to be coded as follows: -1 unknown -99 missing (variable not collected) 0 no 1 yes, at least once during the year of follow-up
5.8 Methicillin-resistant Staphylococcus aureus - MRSA - this year
The ECFSPR requires this variable to be coded as follows: -1 unknown -99 missing (variable not collected) 0 no 1 yes, at least once during the year of follow-up
5.9 Total days on intravenous (IV) antibiotics (for CF-related reasons), at home + in hospital, this year
The ECFSPR requires this variable to be coded as follows: enter the total number of days on intravenous antibiotics, (CF-related reasons), at home and in hospital during the year of f.u. -1 number of days unknown / variable not collected 0 no IV antibiotics during the year of f.u. Include the first and last day.
5.10 Total days on intravenous (IV) antibiotics (for CF-related reasons), in hospital only, this year
The ECFSPR requires this variable to be coded as follows: enter number of days on intravenous antibiotics, (CF-related reasons), in hospital only, during the year of f.u. -1 number of days unknown / variable not collected 0 no IV antibiotics during the year of f.u. Include the first and last day.
5.11 Total days in hospital this year, for any reason, not only CF-related, excluding routine checkup days
The ECFSPR requires this variable to be coded as follows: enter total number of days in hospital (incl. non-CF related but excluding routine check-up), during year of f.u. -1 number of days unknown / variable not collected. 0 zero days in hospital - patient was not recovered for any reason during year of f.u.
6. COMPLICATIONS
6.1 Allergic broncho-pulmonary aspergillosis (ABPA) during the year of follow-up
The ECFSPR requires this variable to be coded as follows: -1 unknown -99 missing (variable not collected) 0 no ABPA during the year of follow-up 1 current ABPA (diagnosed or still treated during the year of follow-up)
The ECFSPR definition for this variable is the following: 1. Acute or subacute clinical deterioration (cough, wheeze, exercise intolerance, exercise-induced asthma, change in pulmonary function, or increased sputum production) not attributable to another etiology; 2. Total IgE > 500 IU/ml; 3. Positive skin prick test for Aspergillus antigen (> 3 mm) or positive specific IgE for A. fumigatus; 4. Either: a. precipitins to A. fumigatus or in vitro demonstration of IgG antibody to A. fumigatus; b. or new or recent abnormalities on chest radiography (infiltrates or mucus plugging) or chest CT (characteristic changes) that have not cleared with antibiotics and standard physiotherapy.
6.2 Distal intestinal obstruction syndrome - DIOS - this year
The ECFSPR requires this variable to be coded as follows: -1 unknown -99 missing (variable not collected) 0 no 1 yes
6.3 Salt Loss Syndrome this year
The ECFSPR requires this variable to be coded as follows: -1 unknown -99 missing (variable not collected) 0 no 1 yes
6.4 Diabetes and type of treatment during the year of follow-up
The ECFSPR requires this variable to be coded as follows: -1 unknown -99 missing (variable not collected) 0 no 1 yes, treated with daily insulin. 2 yes, treated with oral hypoglycaemic agents 3 yes, dietary advice only 4 yes, therapy unknown
6.5 Pneumothorax requiring chest drain during the year of follow-up
The ECFSPR requires this variable to be coded as follows: -1 unknown -99 missing (variable not collected) 0 no 1 yes
6.6 Liver disease during the year of follow-up
The ECFSPR requires this variable to be coded as follows: -1 unknown -99 missing (variable not collected) 0 no 1 cirrhosis with hypertension/hypersplenism 2 cirrhosis without hypertension/hypersplenism 3 cirrhosis, hypertension unknown 4 liver disease without cirrhosis 5 variceal bleeding
The ECFSPR definition for this variable is the following: We adopt the definitions for Liver Disease used by the UK Registry. These definitions discriminate patients with severe liver disease (with portal hypertension) from milder cases (cirrhosis without portal hypertension): a) Cirrhosis with Hypertension: scarring of the liver related to underlying CF, typically in a biliary pattern. Severe liver disease may include portal hypertension and/or hypersplenism; b) Cirrhosis without Hypertension: scarring of the liver relating to underlying CF; c) Liver disease without cirrhosis: this includes fatty liver or viral hepatitis but not biliary cirrhosis.
6.7 Hemoptysis - major over 240 ml - during the year of follow-up
The ECFSPR requires this variable to be coded as follows: -1 unknown -99 missing (variable not collected) 0 never during the year of follow-up 1 yes, at least once during the year of follow-up
Hemoptysis major over 250 ml, (in one day) this year
6.8 Occurrence of malignancy during the year of follow-up
The ECFSPR requires this variable to be coded as follows: -1 unknown -99 missing (variable not collected) 0 no 1 colorectal cancer 2 small bowel cancer 3 lymphoid leukemia 4 testicular cancer 5 breast cancer 6 thryoid gland cancer 7 other/type unknown
6.9 Pancreatic status: faecal elastase
The ECFSPR requires this variable to be coded as follows: -1 unknown -99 missing (variable not collected) 0 no 1 <200 µg/g once 2 <200 µg/g twice 3 ≥200 µg/g once 4 ≥200 µg/g twice
The ECFSPR definition for this variable is the following: Stool fat (van de Kamer) > 4-5 g/d in young children, > 7g/d in children above 10 yrs and adults and/or faecal pancreatic elastase-1 < 200 ug/g. Two determinations are mandatory: faecal fat excretion values of infants below 3 months are contradictory; causes of steatorrhoea, other than those which are pancreas-related, must have been excluded. Pancreatic status will be assessed at the registry level, according to the following: a) Pancreatic insufficiency Faecal elastase <200 µg/g (twice) and Faecal fat high* (twice); b) Pancreatic sufficiency Faecal elastase ≥200 µg/g (twice) and Faecal fat normal* (twice). *according to the definition above.
6.10 Pancreatic status: faecal fat
The ECFSPR requires this variable to be coded as follows: -1 unknown -99 missing (variable not collected) 0 not done 1 high once 2 high twice 3 normal once 4 normal twice
The ECFSPR definition for this variable is the following: Stool fat (van de Kamer) > 4-5 g/d in young children, > 7g/d in children above 10 yrs and adults and/or faecal pancreatic elastase-1 < 200 ug/g. Two determinations are mandatory: faecal fat excretion values of infants below 3 months are contradictory; causes of steatorrhoea, other than those which are pancreas-related, must have been excluded. Pancreatic status will be assessed at the registry level, according to the following: a) Pancreatic insufficiency Faecal elastase <200 µg/g (twice) and Faecal fat high* (twice); b) Pancreatic sufficiency Faecal elastase ≥200 µg/g (twice) and Faecal fat normal* (twice). *according to the definition above.
7. TRANSPLANTS
7.1 Last liver transplant
The ECFSPR requires this variable to be coded as follows: -1 unknown -99 missing (variable not collected) 0 no 1 yes
7.2 Year of last liver transplant
The ECFSPR requires this variable to be coded as follows: 4 digits If LiverTransp = 1 but year of latest liver transplant is unknown, use 9999 If LiverTransp = -1/-99/0, leave blank
7.3 Last lung transplant
The ECFSPR requires this variable to be coded as follows: -1 unknown -99 missing (variable not collected) 0 no 1 yes
7.4 Year of last lung transplant
The ECFSPR requires this variable to be coded as follows: 4 digits If LungTransp = 1 but year of latest lung transplant is unknown, use 9999 If LungTransp = -1/-99/0, leave blank
7.5 Last kidney transplant
The ECFSPR requires this variable to be coded as follows: -1 unknown -99 missing (variable not collected) 0 no 1 yes
7.6 Year of last kidney transplant
The ECFSPR requires this variable to be coded as follows: 4 digits If KidneyTransp = 1 but year of latest kidney transplant is unknown, use 9999 If KidneyTransp = -1/-99/0, leave blank
7.7 Last other transplant
The ECFSPR requires this variable to be coded as follows: -1 unknown -99 missing (variable not collected) 0 no 1 yes
7.8 Year of last other transplant
The ECFSPR requires this variable to be coded as follows: 4 digits If OtherTransp = 1 but year of latest other transplant is unknown, use 9999 If OtherTransp = -1/-99/0, leave blank
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.
Terms & Conditions Privacy policy  Accessibility Sitemap Contact 
© EUROPEAN CYSTIC FIBROSIS SOCIETY 2025. All rights reserved. Website by VidaVia (link is external)
European Cystic Fibrosis Society (ECFS)

Source URL:https://www.ecfs.eu/ecfspr/ecfs-patient-registry-variables-conformity-survey